Venaxis's pivotal APPY1 Test clinical trial data for acute Appendicitis were presented at the American College of Emergency Physicians Scientific...
The EU has given CE Mark approval to the APPY1 blood-based Appendicitis test, from Venaxis. The unique test is designed...
Venaxis has announced that it has filed a 510(k) premarket submission with the FDA for the APPY1 Test, a rapid,...
Venaxis has announced positive top-line results from its pivotal US study of its CE Marked APPY1 Test, a rapid, multiple...
Background: Sarcopenia can contribute to negative outcomes in patients with various lung diseases.
Background: This report presents our experience with laparoscopic repair performed in 118 consecutive patients diagnosed with a perforated peptic ulcer (PPU).
Tetraphase Pharmaceuticals, Inc announced the presentation of positive data from three studies further evaluating its lead compound, Xerava (eravacycline), a...
Parkinson's disease is a chronic neurodegenerative movement disorder affecting people mainly beyond their 50s. Geriatric patients with Parkinson's disease experience a specific profile of comorbidities.
Aims: To evaluate the effect of dulaglutide on body composition in type 2 diabetes mellitus (T2DM) patients undergoing hemodialysis (HD).
Areas covered: Our review summarizes current updates on pathogenesis and clinical management of RA including potential future therapeutic options such as the automated slow-flow ascites pump, chronic outpatient albumin...